objective initial experience fractionated stereotactic radiotherapy srt treatment NUMBER patients secretory nonsecretory pituitary macroadenomas primary endpoints local control documentation mri changes contiguous brain tissues discussed methods NUMBER patients planned 3d planning radionics burlington mass usa received median dose NUMBER gy daily fractions treatments delivered stereotactically dedicated 600sr linear accelerator varian corporation palo alto calif usa immobilization achieved relocatable frame mean tumor size NUMBER cm mean prescription isodose NUMBER mean age NUMBER years NUMBER male NUMBER female mean time NUMBER months range months mean optic chiasm brain stem doses calculated NUMBER NUMBER gy respectively patients evaluated mri scans humphrey visual field tests results posttreatment period local control absence tumor progression achieved patients treatment tolerated patients acute complications visual changes mri proton density changes documented NUMBER patients conclusion preliminary results suggest srt compares favorably conventional radiotherapy achieving local control doses brainstem temporal lobes significantly decreased early white matter changes seen mri srt true frequency grade changes likely underestimated similar changes occur association tumor edema surgery given uncertain neurocognitive significance white matter changes associated treating benign tumors conventional radiotherapy currently treating pituitary adenomas fractionated srt reduce potential sequelae t2 weighted x knife NUMBER gy gill thomas cosman follow NUMBER NUMBER pre postgadolinum enhanced t2 weighted follow NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER